*  Constant currency revenue; constant currency revenue, organic; core revenue; non-GAAP EPS; non-GAAP net income; non-GAAP operating income and margin; non-GAAP gross margin; and free cash flow are
Merit Medical (MMSI) delivered earnings and revenue surprises of 42% and 3.17%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Adagio Appoints COO David Hering As Interim CEO Adagio Therapeutics, Inc., (NASDAQ: ADGI) announced th
Biotech stock extended lower for a second straight week as risk aversion continued to pressure stocks amid geopolitical tensions and macroeconomic worries. On the regulatory front, the Food and Drug A

Earnings Preview: Merit Medical (MMSI) Q4 Earnings Expected to Decline

08:03pm, Thursday, 17'th Feb 2022 Zacks Investment Research
Merit Medical (MMSI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

McKesson (MCK) Q3 Earnings and Revenues Top Estimates

10:45pm, Wednesday, 02'nd Feb 2022 Zacks Investment Research
McKesson (MCK) delivered earnings and revenue surprises of 14.31% and 3.18%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Here's Why You Should Retain Merit Medical (MMSI) Stock For Now

04:35pm, Wednesday, 02'nd Feb 2022 Zacks Investment Research
Investors continue to be optimistic about Merit Medical (MMSI) owing to its progress in the WAVE study and a strong product portfolio.
Investors continue to be optimistic about Merit Medical (MMSI) owing to its progress in the WAVE study and a strong product portfolio.
Chris Senyek, Wolfe Research chief investment strategist, joins 'Power Lunch' to discuss which stocks have been oversold and those investors should watch.
SOUTH JORDAN, Utah, Jan. 17, 2022 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagno
SOUTH JORDAN, Utah, Jan. 17, 2022 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnost

Here's Why You Should Retain Merit Medical (MMSI) Stock For Now

03:26pm, Thursday, 23'rd Dec 2021 Zacks Investment Research
Investors continue to be optimistic about Merit Medical (MMSI) owing to its potential in the Peripheral Intervention arm and a strong product portfolio.
Investors continue to be optimistic about Merit Medical (MMSI) owing to its potential in the Peripheral Intervention arm and a strong product portfolio.
WCM Investment Management LLC decreased its position in Merit Medical Systems, Inc. (NASDAQ:MMSI) by 23.2% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 161,176 shares of the medical instruments suppliers stock after selling 48,557 shares during the quarter. WCM Investment []
The Embolotherapy Product Market research report help builds up a clear view of the market trends and development, identify major players in the industry and estimate main downstream sectors. Moreover, the Embolotherapy Product Market research report examines competitive developments such
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE